217 related articles for article (PubMed ID: 33333147)
41. Comparing the association of GFR estimated by the CKD-EPI and MDRD study equations and mortality: the third national health and nutrition examination survey (NHANES III).
Shafi T; Matsushita K; Selvin E; Sang Y; Astor BC; Inker LA; Coresh J
BMC Nephrol; 2012 Jun; 13():42. PubMed ID: 22702805
[TBL] [Abstract][Full Text] [Related]
42. Reduced glomerular filtration rate and its association with clinical outcome in older patients at risk of vascular events: secondary analysis.
Ford I; Bezlyak V; Stott DJ; Sattar N; Packard CJ; Perry I; Buckley BM; Jukema JW; de Craen AJ; Westendorp RG; Shepherd J
PLoS Med; 2009 Jan; 6(1):e16. PubMed ID: 19166266
[TBL] [Abstract][Full Text] [Related]
43. Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria.
von Scholten BJ; Reinhard H; Hansen TW; Oellgaard J; Parving HH; Jacobsen PK; Rossing P
Diabetologia; 2016 Jul; 59(7):1549-1557. PubMed ID: 27033561
[TBL] [Abstract][Full Text] [Related]
44. 24-hour urine phosphorus excretion and mortality and cardiovascular events.
Palomino HL; Rifkin DE; Anderson C; Criqui MH; Whooley MA; Ix JH
Clin J Am Soc Nephrol; 2013 Jul; 8(7):1202-10. PubMed ID: 23539231
[TBL] [Abstract][Full Text] [Related]
45. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber MA; Franklin S; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T;
Ann Intern Med; 2006 Feb; 144(3):172-80. PubMed ID: 16461961
[TBL] [Abstract][Full Text] [Related]
46. Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study.
Mok Y; Matsushita K; Sang Y; Ballew SH; Grams M; Shin SY; Jee SH; Coresh J
PLoS One; 2016; 11(4):e0153429. PubMed ID: 27092943
[TBL] [Abstract][Full Text] [Related]
47. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
48. Outcomes in adults with systolic blood pressure between 130 and 139 mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial.
Contreras G; Lu L; Tamariz L; Rocco MV; Papademetriou V; Kostis JB; Pisoni R; Glasser SP; Sweeney ME; Basile J; Gren LH; Zamanian S; Cushman WC;
J Hypertens; 2020 Aug; 38(8):1567-1577. PubMed ID: 32371767
[TBL] [Abstract][Full Text] [Related]
49. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: meta-analysis of randomised controlled trials.
; Ninomiya T; Perkovic V; Turnbull F; Neal B; Barzi F; Cass A; Baigent C; Chalmers J; Li N; Woodward M; MacMahon S
BMJ; 2013 Oct; 347():f5680. PubMed ID: 24092942
[TBL] [Abstract][Full Text] [Related]
50. Glomerular filtration rate and albuminuria predict mortality independently from coronary artery calcified plaque in the Diabetes Heart Study.
Cox AJ; Hsu FC; Carr JJ; Freedman BI; Bowden DW
Cardiovasc Diabetol; 2013 Apr; 12():68. PubMed ID: 23594619
[TBL] [Abstract][Full Text] [Related]
51. Parental history of premature cardiovascular disease, estimated GFR, and rate of estimated GFR decline: results from the Aerobics Center Longitudinal Study.
Huang X; Sui X; Ruiz JR; Hirth V; Ortega FB; Blair SN; Carrero JJ
Am J Kidney Dis; 2015 May; 65(5):692-700. PubMed ID: 25600488
[TBL] [Abstract][Full Text] [Related]
52. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Sliwa K; Weber MA; Williams B; Yusuf S
Lancet; 2017 Jun; 389(10085):2226-2237. PubMed ID: 28390695
[TBL] [Abstract][Full Text] [Related]
53. Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT.
Beddhu S; Shen J; Cheung AK; Kimmel PL; Chertow GM; Wei G; Boucher RE; Chonchol M; Arman F; Campbell RC; Contreras G; Dwyer JP; Freedman BI; Ix JH; Kirchner K; Papademetriou V; Pisoni R; Rocco MV; Whelton PK; Greene T
J Am Soc Nephrol; 2019 Aug; 30(8):1523-1533. PubMed ID: 31324734
[TBL] [Abstract][Full Text] [Related]
54. Association between renal function and cardiovascular and all-cause mortality in the community-based elderly population: results from the Specific Health Check and Guidance Program in Japan.
Kon S; Konta T; Ichikawa K; Asahi K; Yamagata K; Fujimoto S; Tsuruya K; Narita I; Kasahara M; Shibagaki Y; Iseki K; Moriyama T; Kondo M; Watanabe T
Clin Exp Nephrol; 2018 Apr; 22(2):346-352. PubMed ID: 28744566
[TBL] [Abstract][Full Text] [Related]
55. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.
Grams ME; Sang Y; Ballew SH; Carrero JJ; Djurdjev O; Heerspink HJL; Ho K; Ito S; Marks A; Naimark D; Nash DM; Navaneethan SD; Sarnak M; Stengel B; Visseren FLJ; Wang AY; Köttgen A; Levey AS; Woodward M; Eckardt KU; Hemmelgarn B; Coresh J
Kidney Int; 2018 Jun; 93(6):1442-1451. PubMed ID: 29605094
[TBL] [Abstract][Full Text] [Related]
56. Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
Majithia A; Bhatt DL; Friedman AN; Miller M; Steg PG; Brinton EA; Jacobson TA; Ketchum SB; Juliano RA; Jiao L; Doyle RT; Granowitz C; Budoff M; Preston Mason R; Tardif JC; Boden WE; Ballantyne CM
Circulation; 2021 Nov; 144(22):1750-1759. PubMed ID: 34706555
[TBL] [Abstract][Full Text] [Related]
57. Diverging association of reduced glomerular filtration rate and albuminuria with coronary and noncoronary events in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Arosio M; Trevisan R; Vedovato M; Cignarelli M; Andreozzi F; Nicolucci A; Pugliese G;
Diabetes Care; 2012 Jan; 35(1):143-9. PubMed ID: 22124714
[TBL] [Abstract][Full Text] [Related]
58. Association of Visit-to-Visit Variability in Kidney Function and Serum Electrolyte Indexes With Risk of Adverse Clinical Outcomes Among Patients With Heart Failure With Preserved Ejection Fraction.
Segar MW; Patel RB; Patel KV; Fudim M; DeVore AD; Martens P; Hedayati SS; Grodin JL; Tang WHW; Pandey A
JAMA Cardiol; 2021 Jan; 6(1):68-77. PubMed ID: 33206129
[TBL] [Abstract][Full Text] [Related]
59. Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease.
Wanner C; Lachin JM; Inzucchi SE; Fitchett D; Mattheus M; George J; Woerle HJ; Broedl UC; von Eynatten M; Zinman B;
Circulation; 2018 Jan; 137(2):119-129. PubMed ID: 28904068
[TBL] [Abstract][Full Text] [Related]
60. Patients with biopsy-proven nephrosclerosis and moderately impaired renal function have a higher risk for cardiovascular disease: 15 years' experience in a single, kidney disease center.
Suzuki H; Kobayashi K; Ishida Y; Kikuta T; Inoue T; Hamada U; Okada H
Ther Adv Cardiovasc Dis; 2015 Jun; 9(3):77-86. PubMed ID: 25838316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
